Biosense Webster, Inc.
Irvine, CA Part of Ethicon, Inc.
- UEI
- LU6KBGZ1A362
- CAGE
- 1LXW3
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Cardinal Health, Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
DL4EXLSMJJJ4
-
Parent
DL4EXLSMJJJ4
- SAM.gov registration date
- Physical address
- 31 Technology Dr #200, Irvine, CA 92618, USA
- Website
- biosensewebster.com
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $49,332 |
| FY2026 | $16,331,241 |
| FY2025 | $13,239,010 |
| FY2024 | $10,872,209 |
| FY2023 | $12,127,449 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $14,390,031 | |
| 2 | Defense Health Agency | $1,805,822 | |
| 3 | Department of Health and Human Services | $184,720 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Abbott Vascular Inc. | Santa Clara, CA | 339112 Surgical and Medical Instrument Manufacturing |
| Biotronik Inc. | Lake Oswego, OR | 339112 Surgical and Medical Instrument Manufacturing |
| Shockwave Medical, Inc. | Santa Clara, CA | 339112 Surgical and Medical Instrument Manufacturing |
| Edwards Lifesciences LLC | Irvine, CA | 339112 Surgical and Medical Instrument Manufacturing |
| Merit Medical Systems Inc. | South Jordan, UT | 339112 Surgical and Medical Instrument Manufacturing |
About the company
Biosense Webster, Inc., a subsidiary of Ethicon, Inc. (Johnson & Johnson), supplies cardiac electrophysiology medical devices and systems to federal healthcare agencies as a prime contractor on a full-and-open, unrestricted commercial basis with no small-business set-aside participation. The company manufactures diagnostic and ablation catheters, cardiac mapping systems (CARTO 3 family), and related electrophysiology equipment under NAICS 339112 (Surgical and Medical Instrument Manufacturing) and PSC J001 (Medical and Surgical Instruments, Equipment, and Supplies), operating from headquarters in Irvine, California.
Biosense Webster's federal footprint centers on the Department of Veterans Affairs and Defense Health Agency. The top five customer entities by award volume—VISN 10, VISN 12, VISN 8, VISN 6, and VISN 22—account for roughly 28 percent of the total award count; by dollar concentration, Defense Health Agency leads with $51.3 million across 95 awards, followed by Department of the Army Medical Command ($34.5 million, 72 awards) and VISN 17 ($34.5 million, 117 awards). Recent representative work includes a $7.5 million delivery order from VISN 12 for VariPulse catheters and cables (October 2025), a $4.2 million indefinite-delivery contract ceiling with VISN 9 for cardiac mapping equipment through September 2030 (October 2025), a $2.5 million delivery order from VISN 17 for J & J Healthcare Systems catheter systems (June 2026), a $184.7 thousand purchase order from FDA for a Pulsed Field Ablation system with training and warranty (September 2026), and a $313.9 thousand delivery order from VISN 23 for Minneapolis VA CARTO system maintenance warranty services (September 2026).
Biosense Webster holds multiple high-value indefinite-delivery vehicles. A $134 million single-award IDC with VA and Defense Health Agency for electrophysiology catheters and cardiovascular devices (ceiling through March 31, 2029, awarded April 1, 2024) is the largest; recent task orders under this vehicle total in the millions, with VISN 12 drawing $7.5 million for VariPulse catheters, VISN 17 drawing $2.5 million for catheter systems, and smaller orders from VISNs 6, 8, 9, and 10. A $4.2 million single-award IDC with Defense Health Agency for cardiac catheters compatible with CARTO3 XP (ceiling through September 30, 2029, awarded October 1, 2024) supports Army Medical Command at Brooke Army Medical Center with firm fixed-price task orders of approximately $800 thousand to $824 thousand. A $3 million single-award Blanket Purchase Agreement with Defense Health Agency for 3D mapping catheters (through November 24, 2029, awarded October 23, 2024) has drawn approximately $1.48 million in six BPA calls between January 2025 and January 2026 to Walter Reed National Military Medical Center and other DHA facilities. A $2.25 million single-award IDC with Defense Health Agency for CARTO Cath Lab systems and maintenance (through September 30, 2025, awarded October 1, 2022) anchored two $750 thousand delivery orders to Fort Sam Houston. A $483 thousand single-award IDC with VISN 9 for cardiac mapping equipment and electrophysiology solutions (through September 30, 2030, awarded October 1, 2025) recently issued a $161 thousand delivery order for preventive maintenance and repair services in Memphis, Tennessee. Additional BPA vehicles include VA11916A0066 (329 task orders, $28 million combined potential value) and 36C10G21A0010 (32 task orders, $12.3 million).
Activity has remained consistent at 37–43 awards per year across 2022–2025; through late September 2026, 24 awards are recorded for 2026. Twenty-three awards with ultimate completion dates in the next twenty-four months carry combined potential value of $13.9 million, representing near-term recompete exposure. The combined federal award footprint across all sources totals 3,878 prime awards worth $464.4 million potential value, with $167.6 million obligated (36 percent drawn). Biosense Webster competes exclusively on a full-and-open basis with no subcontractor role; the vendor is a pure-play federal medical-device supplier to VA and DoD healthcare systems, with no recorded sub-award activity.
Quick answers
Is Biosense Webster, Inc. registered in SAM.gov?
Yes. Biosense Webster, Inc.'s SAM.gov registration is active through August 20, 2027.
How much has Biosense Webster, Inc. received in federal contracts?
Federal contracts obligated $13,239,010 to Biosense Webster, Inc. in fiscal year 2025 and $52,619,240 in fiscal years 2023 through 2027.
How does Biosense Webster, Inc. rank among federal contractors?
Biosense Webster, Inc.'s parent company, Cardinal Health, Inc., ranked #25 in NAICS 339112, #28 in PSC J065 and #38 in NAICS 334510 in FY2025.
What is Biosense Webster, Inc.'s most recent federal award?
Biosense Webster, Inc.'s most recent federal contract award is Procure one pulsed field ablation (PFA) system, including generator, compatible catheters, required accessories/cables… (75F40126P00408), from Food and Drug Administration, on September 28, 2026.
On GovTribe
See Biosense Webster, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors